Cargando…

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes

Objective: Fibroblast growth factor 19 (FGF19) plays an indispensable role in regulating bile acid, glucose, and lipid metabolism, and alterations of its circulating concentration is associated with the development of type 2 diabetes (T2D). Atherosclerosis is directly related to the death-deriving d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jingyi, Liu, Zhiwen, Tong, Yue, Mei, Zubing, Xu, Aimin, Zhou, Pengcheng, Chen, Xiaoyan, Tang, Weili, Zhou, Zhiguang, Xiao, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258879/ https://www.ncbi.nlm.nih.gov/pubmed/32528406 http://dx.doi.org/10.3389/fendo.2020.00282

Ejemplares similares

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
por: Xiao, Yang, et al.
Publicado: (2015)

Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes
por: Xiao, Yang, et al.
Publicado: (2013)

Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial
por: Zhang, Rong, et al.
Publicado: (2022)

Perirenal fat thickness as a superior obesity-related marker of subclinical carotid atherosclerosis in type 2 diabetes mellitus
por: Guo, Xiu Li, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Sex Modifies the Association of Fibroblast Growth Factor 21 With Subclinical Carotid Atherosclerosis
por: Chee, Yingjie, et al.
Publicado: (2021)

Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease
por: Mei, Yufeng, et al.
Publicado: (2022)

Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus
por: Liu, Zhiwen, et al.
Publicado: (2016)

SAT-046 Insulin-Like Growth Factor and Fibroblast Growth Factor 21 in Men with Klinefelter Syndrome
por: Chang, Simon, et al.
Publicado: (2020)

Circulating MicroRNA Profile as a Potential Predictive Biomarker for Early Diagnosis of Spontaneous Abortion in Patients With Subclinical Hypothyroidism
por: Zhou, Yingying, et al.
Publicado: (2018)

Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
por: Hu, Jingyi, et al.
Publicado: (2022)

Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity
por: Mihuta, Monica Simina, et al.
Publicado: (2023)

Association Between C-Peptide Level and Subclinical Myocardial Injury
por: Chen, Ziwei, et al.
Publicado: (2021)

Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes
por: Hu, Jingyi, et al.
Publicado: (2021)

The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis
por: Yu, Xiawen, et al.
Publicado: (2022)

Fibroblast Growth Factor Signaling in Metabolic Regulation
por: Nies, Vera J. M., et al.
Publicado: (2016)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022)

Subclinical Hypothyroidism and Depression: A Systematic Review and Meta-Analysis
por: Tang, Rong, et al.
Publicado: (2019)

Pathological Investigations of Intracranial Atherosclerosis Using Multiple Hypercholesterolemic Rabbit Models
por: Tang, Xiangming, et al.
Publicado: (2022)

Shortening telomere is associated with subclinical atherosclerosis biomarker in omnivorous but not in vegetarian healthy men
por: Cinegaglia, Naiara, et al.
Publicado: (2019)

The Impact of Subclinical Hypothyroidism on Adverse Perinatal Outcomes and the Role of Thyroid Screening in Pregnancy
por: Wu, Mei-Qin, et al.
Publicado: (2019)

Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes
por: Hu, Xiang, et al.
Publicado: (2016)

Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study
por: Zhou, Weili, et al.
Publicado: (2021)

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
por: Wang, Lili, et al.
Publicado: (2021)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016)

CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients
por: Zhou, Fangli, et al.
Publicado: (2021)

Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
por: Calsolaro, Valeria, et al.
Publicado: (2019)

Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease
por: Sue, Laura Y., et al.
Publicado: (2020)

Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
por: Gencer, Baris, et al.
Publicado: (2022)

Relation between Birth Weight, Growth, and Subclinical Atherosclerosis in Adulthood
por: Valente, Maria Helena, et al.
Publicado: (2015)

Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
por: Zhang, Jun, et al.
Publicado: (2015)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Ding, Xiaohong, et al.
Publicado: (2018)

Vascular endothelial growth factor levels in diabetic peripheral neuropathy: a systematic review and meta-analysis
por: Ding, Rui, et al.
Publicado: (2023)

Effects of Maternal Subclinical Hypothyroidism in Early Pregnancy Diagnosed by Different Criteria on Adverse Perinatal Outcomes in Chinese Women With Negative TPOAb
por: Li, Mei-Fang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gs4u91kvoisq15ldt09j6obftf